88 related articles for article (PubMed ID: 16319505)
21. P300 amplitude, externalizing psychopathology, and earlier- versus later-onset substance-use disorder.
Carlson SR; McLarnon ME; Iacono WG
J Abnorm Psychol; 2007 Aug; 116(3):565-77. PubMed ID: 17696712
[TBL] [Abstract][Full Text] [Related]
22. Borderline personality disorder, antisocial personality disorder and risk-taking among heroin users: findings from the Australian Treatment Outcome Study (ATOS).
Darke S; Williamson A; Ross J; Teesson M; Lynskey M
Drug Alcohol Depend; 2004 Apr; 74(1):77-83. PubMed ID: 15072810
[TBL] [Abstract][Full Text] [Related]
23. Protease inhibitor combination therapy, severity of illness, and quality of life among children with perinatally acquired HIV-1 infection.
Storm DS; Boland MG; Gortmaker SL; He Y; Skurnick J; Howland L; Oleske JM;
Pediatrics; 2005 Feb; 115(2):e173-82. PubMed ID: 15629958
[TBL] [Abstract][Full Text] [Related]
24. Correspondence between self-report and interview-based assessments of antisocial personality disorder.
Guy LS; Poythress NG; Douglas KS; Skeem JL; Edens JF
Psychol Assess; 2008 Mar; 20(1):47-54. PubMed ID: 18315398
[TBL] [Abstract][Full Text] [Related]
25. Cognitive slowing in cognitive-motor disorder associated to type 1 human immunodeficiency virus: TR and P300.
Amador Romero F; Pelegrina del Rio M; Mayor Ríos J
Actas Esp Psiquiatr; 2007; 35(4):221-8. PubMed ID: 17592783
[TBL] [Abstract][Full Text] [Related]
26. Antisocial personality disorder is associated with increased severity of gambling, medical, drug and psychiatric problems among treatment-seeking pathological gamblers.
Pietrzak RH; Petry NM
Addiction; 2005 Aug; 100(8):1183-93. PubMed ID: 16042649
[TBL] [Abstract][Full Text] [Related]
27. A prospective controlled study of neurodevelopment in HIV-uninfected children exposed to combination antiretroviral drugs in pregnancy.
Alimenti A; Forbes JC; Oberlander TF; Money DM; Grunau RE; Papsdorf MP; Maan E; Cole LJ; Burdge DR
Pediatrics; 2006 Oct; 118(4):e1139-45. PubMed ID: 16940166
[TBL] [Abstract][Full Text] [Related]
28. Increased health care utilization and increased antiretroviral use in HIV-infected individuals with mental health disorders.
Mijch A; Burgess P; Judd F; Grech P; Komiti A; Hoy J; Lloyd JH; Gibbie T; Street A
HIV Med; 2006 May; 7(4):205-12. PubMed ID: 16630032
[TBL] [Abstract][Full Text] [Related]
29. Role of antiretroviral therapies in mucocutaneous manifestations in HIV-infected children over a period of two decades.
Seoane Reula E; Bellon JM; Gurbindo D; Muñoz-Fernandez MA
Br J Dermatol; 2005 Aug; 153(2):382-9. PubMed ID: 16086754
[TBL] [Abstract][Full Text] [Related]
30. Auditory and visual P300 evoked potentials do not predict response to valproate treatment of aggression in patients with borderline and antisocial personality disorders.
Reeves RR; Struve FA; Patrick G
Clin EEG Neurosci; 2005 Jan; 36(1):49-51. PubMed ID: 15683198
[TBL] [Abstract][Full Text] [Related]
31. Sociopathy, gender, and treatment outcome among outpatient substance abusers.
Galen LW; Brower KJ; Gillespie BW; Zucker RA
Drug Alcohol Depend; 2000 Dec; 61(1):23-33. PubMed ID: 11064181
[TBL] [Abstract][Full Text] [Related]
32. Effect of perospirone on P300 electrophysiological activity and social cognition in schizophrenia: a three-dimensional analysis with sloreta.
Sumiyoshi T; Higuchi Y; Itoh T; Matsui M; Arai H; Suzuki M; Kurachi M; Sumiyoshi C; Kawasaki Y
Psychiatry Res; 2009 Jun; 172(3):180-3. PubMed ID: 19386475
[TBL] [Abstract][Full Text] [Related]
33. Mate similarity for substance dependence and antisocial personality disorder symptoms among parents of patients and controls.
Sakai JT; Stallings MC; Mikulich-Gilbertson SK; Corley RP; Young SE; Hopfer CJ; Crowley TJ
Drug Alcohol Depend; 2004 Aug; 75(2):165-75. PubMed ID: 15276222
[TBL] [Abstract][Full Text] [Related]
34. Brain maturation in conduct disorder versus borderline personality disorder.
Ceballos NA; Houston RJ; Hesselbrock VM; Bauer LO
Neuropsychobiology; 2006; 53(2):94-100. PubMed ID: 16557039
[TBL] [Abstract][Full Text] [Related]
35. Major depression-related immunological changes and combination antiretroviral therapy in HIV-seropositive patients.
Alciati A; Gallo L; Monforte AD; Brambilla F; Mellado C
Hum Psychopharmacol; 2007 Jan; 22(1):33-40. PubMed ID: 17191264
[TBL] [Abstract][Full Text] [Related]
36. Arachidonic acid supplementation decreases P300 latency and increases P300 amplitude of event-related potentials in healthy elderly men.
Ishikura Y; Ikeda G; Akimoto K; Hata M; Kusumoto A; Kidokoro A; Kontani M; Kawashima H; Kiso Y; Koga Y
Neuropsychobiology; 2009; 60(2):73-9. PubMed ID: 19752581
[TBL] [Abstract][Full Text] [Related]
37. Effects of borderline personality disorder features and a family history of alcohol or drug dependence on P300 in adolescents.
Houston RJ; Bauer LO; Hesselbrock VM
Int J Psychophysiol; 2004 Jun; 53(1):57-70. PubMed ID: 15172136
[TBL] [Abstract][Full Text] [Related]
38. The role of antisocial and borderline personality features in substance dependence among incarcerated females.
Chapman AL; Cellucci T
Addict Behav; 2007 Jun; 32(6):1131-45. PubMed ID: 16962249
[TBL] [Abstract][Full Text] [Related]
39. The interactive effects of antisocial personality disorder and court-mandated status on substance abuse treatment dropout.
Daughters SB; Stipelman BA; Sargeant MN; Schuster R; Bornovalova MA; Lejuez CW
J Subst Abuse Treat; 2008 Mar; 34(2):157-64. PubMed ID: 17869050
[TBL] [Abstract][Full Text] [Related]
40. Sensorimotor dysfunction in HIV/AIDS: effects of antiretroviral treatment and comorbid psychiatric disorders.
Bauer LO; Ceballos NA; Shanley JD; Wolfson LI
AIDS; 2005 Mar; 19(5):495-502. PubMed ID: 15764855
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
